Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2007-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1211/jpp.59.1.0006PMID 17227619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In‐vitro and in‐vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis

  2006cited by this paper
• What is the Future of Diabetic Wound Care?

  2006cited by this paper
• Advances in leishmaniasis.

  2005cited by this paper
• Recent developments in Leishmaniasis: Epidemiology, diagnosis, and treatment

  2005cited by this paper
• Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.

  2004cited by this paper
• Penetration enhancers.

  2004cited by this paper
• Toxicity and human health risk of hair dyes.

  2004cited by this paper
• Leishmaniasis: current situation and new perspectives.

  2004influential reference
• Binding of primaquine to epidermal membranes and keratin.

  2003cited by this paper
• Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.

  2003cited by this paper
• Topical treatment for cutaneous leishmaniasis.

  2002cited by this paper
• Silicones as Excipients for Topical Pharmaceutical Applications The Silky Touch Product Family from Dow Corning

  2002cited by this paper
• Binding of doxycycline to keratin, melanin and human epidermal tissue.

  2002cited by this paper
• Skin, the final frontier.

  2001cited by this paper
• Stripping method to quantify absorption of two sunscreens in human.

  2001cited by this paper
• Veterinary drug delivery: potential for skin penetration enhancement.

  2001cited by this paper
• Physical and physiological effects of stratum corneum tape stripping

  2001cited by this paper
• A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis.

  2000cited by this paper
• Studies on the binding mechanism of fluoroquinolones to melanin

  2000cited by this paper
• U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.

  1999cited by this paper
• U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.

  1999cited by this paper
• Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels.

  1999cited by this paper
• The selection and design of topical and transdermal agents: a review.

  1998cited by this paper
• In vitro evaluation of percutaneous absorption of an acyclovir product using intact and tape-stripped human skin.

  1998cited by this paper
• Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis.

  1998cited by this paper
• Comparative in vitro skin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse.

  1997cited by this paper
• Comparativein VitroSkin Absorption and Metabolism of Coumarin (1,2-Benzopyrone) in Human, Rat, and Mouse

  1997cited by this paper
• The role of percutaneous penetration enhancers

  1996cited by this paper
• The release of clindamycin phosphate from a suspension of different types of liposomes and selected topical dosages forms

  1996cited by this paper
• Methods for Assessing Percutaneous Absorption

  1996cited by this paper
• A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran.

  1995cited by this paper
• Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.

  1995cited by this paper
• A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment.

  1995cited by this paper
• Interaction between chemicals and melanin.

  1993cited by this paper
• The activity of hydroxynaphthoquinones against Leishmania donovani.

  1992cited by this paper
• Parvaquone and buparvaquone: HPLC analysis and comparative pharmacokinetics in cattle.

  1988cited by this paper
• Covalently bound ω-hydroxyacylsphingosine in the stratum corneum

  1987cited by this paper
• Covalently bound omega-hydroxyacylsphingosine in the stratum corneum.

  1987cited by this paper
• Topical treatment of cutaneous leishmaniasis.

  1986cited by this paper
• Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals

  1984cited by this paper
• PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM.

  1963cited by this paper

• Development and Validation of Novel Ultraviolet Spectrophotometric Method for Estimation of Antileishmanial Drug Buparvaquone

  2022cites this paper
• Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review

  2021cites this paper
• Topical Buparvaquone Nano-enabled Hydrogels for Cutaneous Leishmaniasis.

  2020cites this paper
• Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs

  2020cites this paper
• Novel Therapeutic Approaches for the Treatment of Leishmaniasis

  2019cites this paper
• Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis

  2019cites this paper
• Drug-containing hydrophobic dressings as a topical experimental therapy for cutaneous leishmaniasis

  2019cites this paper
• Development of topical liposomes containing miltefosine for the treatment of Leishmania major infection in susceptible BALB/c mice.

  2019cites this paper
• Evaluation of Skin Permeation and Retention of Topical Dapsone in Murine Cutaneous Leishmaniasis Lesions

  2019cites this paper
• Pharmaco- and immunotherapeutic strategies for the topical treatment of cutaneous leishmaniasis

  2017cites this paper
• Leishmania and other intracellular pathogens: selectivity, drug distribution and PK–PD

  2017cites this paper
• Design of treatments for cutaneous and visceral leishmaniasis.

  2017cites this paper
• Informative title : Drug permeation and barrier damage in Leishmania-infected mouse skin

  2016cites this paper
• Effect of Topical Morphine on Cutaneous Leishmaniasis in an Animal Model: A Preliminary Report

  2016cites this paper
• Cutaneous Leishmaniasis in Iraq : A Continuing Endemic Disease

  2016cites this paper
• Nanoparticles in the Topical Treatment of Cutaneous Leishmaniasis: Gaps, Facts, and Perspectives

  2016cites this paper
• Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice

  2015cites this paper
• In vitro Studies on the Antileishmanial Activity of Herbicides and Plant Extracts Against Leishmania major Parasites

  2015influential citation
• Permeación en piel humana de una nanoemulsión de ftalocianina de aluminio clorada para la optimización de tratamientos tópicos de leishmaniasis cutánea

  2014cites this paper
• Permeación en piel humana de una nanoemulsión de ftalocianina de aluminio clorada para la optimización de tratamientos tópicos de leishmaniasis cutánea

  2014influential citation
• Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis

  2014cites this paper
• Drug delivery systems for the topical treatment of cutaneous leishmaniasis

  2012cites this paper
• Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development

  2011cites this paper
• Leishmaniasis chemotherapy--challenges and opportunities.

  2011cites this paper
• ESTUDO IN VITRO DE FÁRMACOS SINTÉTICOS EM LESHMANIA (L.) CHAGASI

  2010cites this paper
• Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management

  2010cites this paper
• Open Access SHORT COMMUNICATION

  2010cites this paper
• Was the Justinian Plague caused by the 1918 flu virus?

  2009cites this paper
• Intralesional artemisinin for the treatment of cutaneous leishmaniasis.

  2009cites this paper
• In‐vitro permeation of drugs into porcine hair follicles: is it quantitatively equivalent to permeation into human hair follicles?

  2008cites this paper
• Topical morphine for the treatment of cutaneous leishmaniasis.

  2008cites this paper
• In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.

  2007cites this paper